does glp 1 cause osteoporosis affect bone density Effects of Glucagon-Like Peptide-1 receptor agonists on health in people living with obesity Effects of Glucagon-Like Peptide-1 receptor

481 RNF5 was shown to promote the degradation of misfolded SLC1A5 and SLC38A2 after paclitaxel treatment of breast cancer cells, which resulted in decreased glutamine uptake and increased apoptosis of breast cancer cells

10.1016/j.isci.2023.107909 16 CaiC.KozmaC.PatelC.BensonC.YunusaI.ZhaoP.et al (2024)

Over time, chronic energy deficiency can lead to fatigue, poor recovery, loss of muscle, hormonal disturbances, low energy availability and impaired performance a condition akin to RED-S (Relative Energy Deficiency in Sport)

Researchers found that people who took this medication: Lost an average of 15% of their total body weight 1 in 3 participants lost 20%

** ( )